Quarterly report [Sections 13 or 15(d)]

Stockholders??? Equity (Tables)

v3.25.2
Stockholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2025
Stockholders’ Equity [Abstract]  
Schedule of Net Proceeds

The table below details the net proceeds of the 2021 Public Offering.

 

Gross Proceeds:      
     Initial Closing   $ 39,999,040  
     Option Closing     6,000,000  
      45,999,040  
Offering Costs:        
     Underwriting discounts and commissions     (2,500,000 )
     Other offering costs     (821,957 )
Net Proceeds   $ 42,677,083  
Schedule of Warrants Activity

A summary of our Warrants activity for the six months ended June 30, 2025 and related information follows:

 

    Number of
Shares
Under
Warrant
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Life
 
Balance as of January 1, 2025     26,490,110     $ 1.70       3.84  
Granted     9,600,000       0.00          
Exercised     (18,972,168 )     0.52          
Cancelled     (289,253 )     7.46          
Balance as of June 30, 2025     16,828,689     $ 1.45       3.48  
Schedule of Assumptions Used in the Black-Scholes Model

The assumptions used in the Monte Carlo simulation and Black-Scholes Model are set forth in the table below.

 

    Six Months 
Ended
June 30,
2025
 
Stock price   $ 0.77-2.69  
Risk-free interest rate     3.86-4.65 %
Volatility     59.05-88.69 %
Expected life in years     5.00-5.77  
Dividend yield     0.00 %
Schedule of Option Activity

A summary of our Option activity for the three and six months ended June 30, 2025 and related information follows:

 

    Number of
Shares
Under
Option
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Life
 
Balance as of January 1, 2025     4,289,359     $ 3.70       7.59  
Granted     13,301,944       1.48          
Exercised     (22,082 )     0.49          
Forfeited     (59,709 )     1.16          
Canceled     (26,958 )     1.46          
Balance as of June 30, 2025     17,482,554     $ 2.03       8.29  
Vested and Exercisable as of June 30, 2025     3,698,944     $ 4.03       7.04  
Schedule of Stock-Based Compensation Expense for Stock Options

Total stock-based compensation expense for stock options for the three and six months ended June 30, 2025 and 2024 is as follows:

 

    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2025     2024     2025     2024  
General and administrative   $ 875,781     $ 218,635     $ 1,664,063     $ 290,218  
Sales and marketing     135,612       80,412       134,391       151,966  
Research and development     136,060       37,089       205,197       77,405  
Cost of goods sold     125,297       19,108       193,993       37,048  
Total stock-based expense related to options   $ 1,272,750     $ 355,244     $ 2,197,644     $ 556,637  

Total stock-based compensation expense for RSUs for the three and six months ended June 30, 2025 and 2024 is as follows:

 

    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2025     2024     2025     2024  
General and administrative   $ 637,873     $ 48,477     $ 924,186     $ 106,634  
Sales and marketing     56,537       4,065       210,958       13,564  
Research and development     52,768       211       103,561       715  
Cost of goods sold     67,844      
-
      133,149      
-
 
Total stock-based expense related to restricted stock units   $ 815,022     $ 52,753     $ 1,371,854     $ 120,913  
Schedule of Restricted Stock Unit (RSUs) Activity

A summary of our RSUs activity and related information is as follows: 

 

    RSUs     Weighted
Average
Grant Date
Fair Value
    Weighted
Average
Vesting
Period
(Years)
 
Unvested balance at January 1, 2025     252,417     $ 0.68       0.75  
Granted     4,218,399     $ 1.33          
Vested     (730,578 )   $ 1.44          
Unvested balance at June 30, 2025     3,740,238     $ 1.26       1.75